Skip to main content
Clinical Trials/NCT06226272
NCT06226272RecruitingNot Applicable

Clinical Outcome Measure at Stryker Spine: COMPASS

VB Spine, LLC7 sites in 1 country5,222 target enrollmentStarted: January 28, 2025Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
5,222
Locations
7
Primary Endpoint
S-S-102-C

Study Overview

Brief Summary

This is a multicenter, prospective, retrospective, Post Market Clinical Follow-up (PMCF) study in subjects who have undergone or will undergo surgery utilizing one or more Stryker devices according to Stryker cleared Instructions for Use (IFU).

Detailed Description

Stryker Spine has a broad portfolio of spinal devices used to stabilize the spine. This PMCF study is designed to collect data on the performance and safety of the devices over their lifetime of 24 months post-implantation. Four protocols have been designed to aid in this process, a master and three sub-protocols. The sub-protocols are based on body region and indication:

  • S-S-102-A Cervical: Interbody Devices (IBDs), Vertebral Body Replacement Devices (VBRs), Internal Fixation Devices, and Vitoss
  • S-S-102-B Thoracolumbar: IBDs, VBRs, Internal Fixation Devices, and Vitoss
  • S-S-102-C Adult Spinal Deformities: IBDs, Internal Fixation Devices, and Vitoss Each of the sub-protocols has its own specific performance endpoint and hypothesis, radiographical data assessments, and SAPs. Safety data will be collected throughout the study.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Other

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • To be eligible to participate in the study, the potential subject must meet all inclusion criteria specific to the Stryker system being evaluated, please contact one of the participating investigators or see the device-specific cleared IFU, for further details.

Exclusion Criteria

  • The exclusion criteria are based on the contraindications as presented in the Stryker device cleared IFUs, please contact one of the participating investigators or see the device-specific cleared IFU, for further details.

Outcomes

Primary Outcomes

S-S-102-C

Time Frame: Baseline through 24-months post-op.

Mean change in the subject's Scoliosis Research Society-22 revised (SRS-22r).

S-S-102-A

Time Frame: Baseline through 24-months post-op.

Mean change in the subject's Neck Disability Index (NDI) score.

S-S-102-B

Time Frame: Baseline through 24-months post-op.

Mean change in the subject's Oswestry Disability Index (ODI) score.

Secondary Outcomes

  • S-S-102-A(Surgery through 24-months post-op.)
  • S-S-102-B(Surgery through 24-months post-op.)
  • S-S-102-C(Surgery through 24-months post-op.)

Investigators

Sponsor
VB Spine, LLC
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (7)

Loading locations...

Similar Trials

Clinical Outcome Measure at Stryker Spine | Clinical Trial